Managers

Health2047 Capital Partners seeks $250 mln for debut fund

Healthcare-focused Health2047 Capital Partners is seeking to raise $250 million for its inaugural fund, according to a regulatory filing. The Menlo Park, California-based firm is led by Managing Partners Joe Boystak, Tom Frederick and Doug Given.

Monashees targets $150 mln for eighth fund

Monashees is seeking to raise $150 million for its eighth fund, according to an SEC filing. The Brazilian venture firm invests in "entrepreneurs committed to creating innovative solutions for a new world."

Georgian Partners raises bulk of $500 mln Fund IV, doubles GP team

Georgian Partners raises bulk of $500 mln Fund IV, doubles GP team

Georgian Partners has raised most of the US$500 million ($645 million) target set for its fourth fund, as the firm executes an ambitious plan to broaden its reach in the North American market. Georgian Partners Growth Fund IV has so far secured US$450 million ($580 million), a source told PE Hub Canada. It is expected to cross the finish line in the weeks ahead, possibly at or near its hard cap of US$550 million. If successful, the fund would be Georgian’s largest to date and one of Canada’s largest private tech partnerships on record.

Coinbase launches new venture fund: CNBC

Cryptocurrency exchange Coinbase is launching a new venture capital fund that will back early-stage startups in the cryptocurrency and blockchain space, according to a report by CNBC. The fund has already raised $15 million.

Q1 investing tops $21 bln for 2nd time since dot-com bubble

Makers Fund raises $200 mln for fund

Makers Fund, which is focused on the global interactive entertainment industry, has raised $200 million for its venture fund. Since last summer, Makers Fund has invested in 11 unidentified companies. Makers Fund was founded by Jay Chi and Michael Cheung.

Panacea Venture, backed by KPCB partners, to raise $150 mln for venture fund

Panacea Venture, formed by two Kleiner Perkins Caufield Byers' partners from China, is seeking to raise $150 million for a venture fund according to a filing with the SEC.

RefleXion Medical rakes in over $100 mln Series C

Hayward, California-based RefleXion Medical, a developer of biology-guided radiotherapy system for targeted cancer treatment, has raised more than $100 million in Series C funding. The Rise Fund, an impact investment fund managed by TPG Growth, led the round with participation from other investors that included T. Rowe Price Associates, Inc, GT Healthcare Capital Partners, Sofinnova Partners, KCK Group, Venrock, Pfizer Venture Investments and Johnson & Johnson Innovation – JJDC Inc.

ITBMed pulls $67 mln

ITBMed has raised up to $67 million in funding. Pablo Legorreta, the founder and CEO of Royalty Pharma, was the lead investor. Carnegie Investment Bank advised ITBMed on the transaction with Baker McKenzie providing legal advice. And, Goodwin Procter LLP was legal adviser to Pablo Legorreta. Based in Sweden, ITBMed is a biopharmaceutical company developing specific immunomodulatory biologics for organ transplantation, stem cell transplantation and gene therapy.